Traduction de «Medical Staff - Statement Clinical Privileges » (Anglais → Français) :

Medical Staff - Statement of Clinical Privileges

staff privileges [ medical staff privileges ]

34. Underlines that even when legal, abortion is often prevented or delayed by obstacles to the access of appropriate services, such as the widespread use of conscientious objection, medically unnecessary waiting periods or biased counselling; stresses that the Member States should regulate and monitor the use of conscientious objection in the key professions, so as to ensure that reproductive healthcare is guaranteed as an individual’s right, while access to lawful services is ensured and appropriate public referrals systems of good quality are in place; stresses that the right to conscientious objection is an individual right and not ...[+++] a collective policy, and that advice and counselling must be confidential and non-judgmental; is concerned that medical staff are coerced into refusing SRHR services in religion-based hospitals and clinics throughout the EU;

35. Underlines that even when legal, abortion is often prevented or delayed by obstacles to the access of appropriate services, such as the widespread use of conscientious objection, medically unnecessary waiting periods or biased counselling; stresses that Member States should regulate and monitor the use of conscientious objection in the key professions, so as to ensure that reproductive health care is guaranteed as an individual’s right, while access to lawful services is ensured and appropriate public referrals systems of good quality are in place; stresses that the right to conscientious objection is an individual right and not a ...[+++]collective policy, and that advice and counselling must be confidential and non-judgmental; is concerned that medical staff are coerced into refusing SRHR services in religion-based hospitals and clinics throughout the EU;

28. Encourages taking immediate action to create a financial environment for research into the prevention of further outbreaks, and to coordinate and strengthen medical research and the production of effective medicines, clinical tests and policies, not only against Ebola but also against certain other epidemic-prone, life-threatening infectious diseases that cause a high number of deaths in Africa, and to publish the data regarding vaccine safety and effectiveness; stresses the necessity of not withdrawing from research efforts, giv ...[+++]en the need for continuous control of the epidemic, taking care to secure ethical conditions for the trials by means of informed prior consent of the patients who take part in the trials, transparency in the clinical data resulting from this research and effective access to these vaccines and treatments by the populations concerned (qualified staff and adequate infrastructure for care delivery, with the price not exceeding the real cost of production); expects the grant agreements of the Ebola+ programme to be made public with regard to their conditions and award procedures;

a list of medical devices which are to be investigated in the clinical trial but which are not part of the investigational medicinal product or products, together with a statement as to whether the medical devices are CE-marked for the intended use.